Turning Point Therapeutics
About:
Turning Point Therapeutics is a pharmaceutical company that discovers and develops precision medicines for cancer and other diseases.
Website: http://www.tptherapeutics.com
Twitter/X: TPTherapeutics
Top Investors: OrbiMed, Foresite Capital, Cormorant Asset Management, SR One, Lilly Asia Ventures
Description:
Turning Point Therapeutics is a clinical-stage structure-based drug design company for the discovery and development of precision medicines for cancer and other diseases. They focus on the design of novel chemical identities for established oncogene drivers with secondary resistant mutations, newly identified disease-driven targets, and potential targets regulating the tumor microenvironment and tumor immunity.
$1.18B
$100M to $500M
San Diego, California, United States
2013-10-08
peter.li(AT)tptherapeutics.com
J. Jean Cui, Y. Peter Li
251-500
2020-10-26
Delisted
© 2025 bioDAO.ai